HighTower Advisors’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
Other funds holding CRBU
HighTower Advisors's CRBU Position: Q3 2026 in Review
HighTower Advisors increased its Caribou Biosciences (CRBU) stake by 5.9% in Q3 2026, buying an estimated $1.56K and bringing the position to 17,934 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3789.
HighTower Advisors first reported a position in CRBU in Q4 2024 and has held it in 8 quarters since. The position peaked at $39.5K in Q3 2025. 113 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.
- HighTower Advisors held 17,934 shares of Caribou Biosciences worth $22.8K as of Q3 2026.
- HighTower Advisors bought 1,000 Caribou Biosciences shares in Q3 2026, an estimated $1.56K.
- Caribou Biosciences made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3789 holding.
- HighTower Advisors first reported a position in Caribou Biosciences in Q4 2024 and has held it in 8 quarters since.
- HighTower Advisors's Caribou Biosciences position peaked at $39.5K in Q3 2025.
- 113 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.